(MENAFN- GlobeNewsWire - Nasdaq) English Dutch PRESS RELEASE: REGULATED INFORMATION
2 December 2022, 17:45 CET
Disclosure of a transparency notification
Mechelen, Belgium, 2 December 2022 – Biocartis Group NV (the ' Company ' or ' Biocartis '), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today, in accordance with Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers of which shares are admitted to trading on a regulated market and laying down miscellaneous provisions (the ' Belgian Transparency Act '), that it received a transparency notification dated 29 November 2022 (the ' Notification ') indicating that on 24 November 2022 the aggregate number of voting rights and equivalent financial instruments held by Credit Suisse (Schweiz) AG, a subsidiary of Credit Suisse Group AG, increased to 3.62%, as further explained below. The Notification is based on a denominator amounting to 58,416,956, disclosed by the press release dated 28 october 2022 . It is to be noted that the denominator as of today amounts to 92,061,563.
The Notification contains the following information:
Reason for the Notification : Acquisition or disposal of voting securities or voting rights.
Notification by : A parent undertaking or a controlling person.
Person subject to the notification requirement : Credit Suisse Group AG, Paradeplatz 8, CH-8001 Zürich, Switzerland.
Transaction date : 24 November 2022.
Threshold that is crossed : 3%.
Denominator : 58,416,956.
Details of the Notification: The Notification sets out that it concerns a group notification with a crossing of the 3% threshold at subsidiary level. Credit Suisse (Schweiz) AG, a subsidiary of Credit Suisse Group AG, now holds an aggregate number of 2,112,084 voting rights and equivalent financial instruments (i.e., shares which it has out on loan to third parties with a right to recall). The parent company Credit Suisse Group AG now has an aggregate position of 3.62% (as compared to 3.68% notified to Biocartis on 2 February 2022).
Full chain of controlled undertakings through which the holding is effectively being held : Credit Suisse Group AG, Credit Suisse AG, Credit Suisse (Schweiz) AG.
MENAFN02122022004107003653ID1105260968
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.